Home |
Help |
Advanced search
2025-05-09 19:08:56, GGRNA : RefSeq release 60 (20130726)
LOCUS NM_015276 5220 bp mRNA linear PRI 01-JUL-2013
DEFINITION Homo sapiens ubiquitin specific peptidase 22 (USP22), mRNA.
ACCESSION NM_015276 XM_042698 XM_945855
VERSION NM_015276.1 GI:150010638
KEYWORDS RefSeq.
SOURCE Homo sapiens (human)
ORGANISM Homo sapiens
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
Catarrhini; Hominidae; Homo.
REFERENCE 1 (bases 1 to 5220)
AUTHORS Armour,S.M., Bennett,E.J., Braun,C.R., Zhang,X.Y., McMahon,S.B.,
Gygi,S.P., Harper,J.W. and Sinclair,D.A.
TITLE A high-confidence interaction map identifies SIRT1 as a mediator of
acetylation of USP22 and the SAGA coactivator complex
JOURNAL Mol. Cell. Biol. 33 (8), 1487-1502 (2013)
PUBMED 23382074
REMARK GeneRIF: study identified the deubiquitinating enzyme
ubiquitin-specific protease 22 (USP22), a component of the
deubiquitinating module (DUBm) of the SAGA transcriptional
coactivating complex, as a SIRT1-interacting partner
REFERENCE 2 (bases 1 to 5220)
AUTHORS Li,J., Wang,Z. and Li,Y.
TITLE USP22 nuclear expression is significantly associated with
progression and unfavorable clinical outcome in human esophageal
squamous cell carcinoma
JOURNAL J. Cancer Res. Clin. Oncol. 138 (8), 1291-1297 (2012)
PUBMED 22447106
REMARK GeneRIF: Data show that USP22 protein plays an essential role in
esophageal squamous cell carcinoma (ESCC) progression and has
clinical potentials as a biomarker and as an attractively
therapeutic target for ESCC.
REFERENCE 3 (bases 1 to 5220)
AUTHORS Xiong,J., Che,X., Li,X., Yu,H., Gong,Z. and Li,W.
TITLE Cloning and characterization of the human USP22 gene promoter
JOURNAL PLoS ONE 7 (12), E52716 (2012)
PUBMED 23300749
REMARK GeneRIF: Sp1 is a crucial regulator of USP22 transcription.
REFERENCE 4 (bases 1 to 5220)
AUTHORS Ling,S.B., Sun,D.G., Tang,B., Guo,C., Zhang,Y., Liang,R. and
Wang,L.M.
TITLE Knock-down of USP22 by small interfering RNA interference inhibits
HepG2 cell proliferation and induces cell cycle arrest
JOURNAL Cell. Mol. Biol. (Noisy-le-grand) 58 (SUPPL), OL1803-OL1808 (2012)
PUBMED 23217440
REMARK GeneRIF: The USP22 regulates the cell cycle via the c--Myc/cyclin
D2 pathway and down--regulating p15 and p21 expression in HepG2
cell.
Publication Status: Online-Only
REFERENCE 5 (bases 1 to 5220)
AUTHORS Piao,S., Liu,Y., Hu,J., Guo,F., Ma,J., Sun,Y. and Zhang,B.
TITLE USP22 is useful as a novel molecular marker for predicting disease
progression and patient prognosis of oral squamous cell carcinoma
JOURNAL PLoS ONE 7 (8), E42540 (2012)
PUBMED 22880026
REMARK GeneRIF: This is the first study that determines the relationship
between USP22 expression and prognosis in oral squamous cell
carcinoma.
REFERENCE 6 (bases 1 to 5220)
AUTHORS Zhao,Y., Lang,G., Ito,S., Bonnet,J., Metzger,E., Sawatsubashi,S.,
Suzuki,E., Le Guezennec,X., Stunnenberg,H.G., Krasnov,A.,
Georgieva,S.G., Schule,R., Takeyama,K., Kato,S., Tora,L. and
Devys,D.
TITLE A TFTC/STAGA module mediates histone H2A and H2B deubiquitination,
coactivates nuclear receptors, and counteracts heterochromatin
silencing
JOURNAL Mol. Cell 29 (1), 92-101 (2008)
PUBMED 18206972
REMARK GeneRIF: ATXN7L3, USP22, & ENY2 are required cofactors for full
transcriptional activity by nuclear receptors. The deubiquitinase
activity of TFTC/STAGA HAT counteracts heterochromatin silencing &
is a positive cofactor for in vivo nuclear receptor activation.
REFERENCE 7 (bases 1 to 5220)
AUTHORS Lee,H.J., Kim,M.S., Shin,J.M., Park,T.J., Chung,H.M. and Baek,K.H.
TITLE The expression patterns of deubiquitinating enzymes, USP22 and
Usp22
JOURNAL Gene Expr. Patterns 6 (3), 277-284 (2006)
PUBMED 16378762
REFERENCE 8 (bases 1 to 5220)
AUTHORS Glinsky,G.V., Berezovska,O. and Glinskii,A.B.
TITLE Microarray analysis identifies a death-from-cancer signature
predicting therapy failure in patients with multiple types of
cancer
JOURNAL J. Clin. Invest. 115 (6), 1503-1521 (2005)
PUBMED 15931389
REMARK GeneRIF: Altered mRNA expression is associated with therapy failure
and death in patients multiple types of cancer.
REFERENCE 9 (bases 1 to 5220)
AUTHORS Puente,X.S., Sanchez,L.M., Overall,C.M. and Lopez-Otin,C.
TITLE Human and mouse proteases: a comparative genomic approach
JOURNAL Nat. Rev. Genet. 4 (7), 544-558 (2003)
PUBMED 12838346
REMARK Review article
REFERENCE 10 (bases 1 to 5220)
AUTHORS Bagheri-Fam,S., Ferraz,C., Demaille,J., Scherer,G. and Pfeifer,D.
TITLE Comparative genomics of the SOX9 region in human and Fugu rubripes:
conservation of short regulatory sequence elements within large
intergenic regions
JOURNAL Genomics 78 (1-2), 73-82 (2001)
PUBMED 11707075
COMMENT VALIDATED REFSEQ: This record has undergone validation or
preliminary review. The reference sequence was derived from
AB028986.1, BX640815.1 and AL110213.1.
On or before Jun 30, 2007 this sequence version replaced
gi:113426697, gi:113427325.
Publication Note: This RefSeq record includes a subset of the
publications that are available for this gene. Please see the Gene
record to access additional publications.
##Evidence-Data-START##
Transcript exon combination :: AB028986.1 [ECO:0000332]
RNAseq introns :: mixed/partial sample support
ERS025081, ERS025082 [ECO:0000350]
##Evidence-Data-END##
PRIMARY REFSEQ_SPAN PRIMARY_IDENTIFIER PRIMARY_SPAN COMP
1-524 AB028986.1 1-524
525-1342 BX640815.1 107-924
1343-1859 AB028986.1 1343-1859
1860-2820 BX640815.1 1443-2403
2821-3041 AB028986.1 2822-3042
3042-4222 BX640815.1 2625-3805
4223-5216 AB028986.1 4230-5223
5217-5220 AL110213.1 1493-1496
FEATURES Location/Qualifiers
source 1..5220
/organism="Homo sapiens"
/mol_type="mRNA"
/db_xref="taxon:9606"
/chromosome="17"
/map="17p11.2"
gene 1..5220
/gene="USP22"
/gene_synonym="USP3L"
/note="ubiquitin specific peptidase 22"
/db_xref="GeneID:23326"
/db_xref="HGNC:12621"
/db_xref="MIM:612116"
exon 1..375
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
CDS 205..1782
/gene="USP22"
/gene_synonym="USP3L"
/EC_number="3.4.19.12"
/note="ubiquitin specific protease 22; ubiquitin
thiolesterase 22; ubiquitin-specific processing protease
22; deubiquitinating enzyme 22; ubiquitin thioesterase 22;
ubiquitin-specific-processing protease 22"
/codon_start=1
/product="ubiquitin carboxyl-terminal hydrolase 22"
/protein_id="NP_056091.1"
/db_xref="GI:150010639"
/db_xref="CCDS:CCDS42285.1"
/db_xref="GeneID:23326"
/db_xref="HGNC:12621"
/db_xref="MIM:612116"
/translation="
MVSRPEPEGEAMDAELAVAPPGCSHLGSFKVDNWKQNLRAIYQCFVWSGTAEARKRKAKSCICHVCGVHLNRLHSCLYCVFFGCFTKKHIHEHAKAKRHNLAIDLMYGGIYCFLCQDYIYDKDMEIIAKEEQRKAWKMQGVGEKFSTWEPTKRELELLKHNPKRRKITSNCTIGLRGLINLGNTCFMNCIVQALTHTPLLRDFFLSDRHRCEMQSPSSCLVCEMSSLFQEFYSGHRSPHIPYKLLHLVWTHARHLAGYEQQDAHEFLIAALDVLHRHCKGDDNGKKANNPNHCNCIIDQIFTGGLQSDVTCQVCHGVSTTIDPFWDISLDLPGSSTPFWPLSPGSEGNVVNGESHVSGTTTLTDCLRRFTRPEHLGSSAKIKCSGCHSYQESTKQLTMKKLPIVACFHLKRFEHSAKLRRKITTYVSFPLELDMTPFMASSKESRMNGQYQQPTDSLNNDNKYSLFAVVNHQGTLESGHYTSFIRQHKDQWFKCDDAIITKASIKDVLDSEGYLLFYHKQFLEYE
"
misc_feature 391..573
/gene="USP22"
/gene_synonym="USP3L"
/note="Zn-finger in ubiquitin-hydrolases and other
protein; Region: zf-UBP; pfam02148"
/db_xref="CDD:202130"
misc_feature 589..591
/gene="USP22"
/gene_synonym="USP3L"
/experiment="experimental evidence, no additional details
recorded"
/note="N6-acetyllysine; propagated from
UniProtKB/Swiss-Prot (Q9UPT9.2); acetylation site"
misc_feature 724..1755
/gene="USP22"
/gene_synonym="USP3L"
/note="Ubiquitin carboxyl-terminal hydrolase; Region: UCH;
pfam00443"
/db_xref="CDD:201230"
misc_feature 730..1758
/gene="USP22"
/gene_synonym="USP3L"
/note="A subfamily of Peptidase C19. Peptidase C19
contains ubiquitinyl hydrolases. They are intracellular
peptidases that remove ubiquitin molecules from
polyubiquinated peptides by cleavage of isopeptide bonds.
They hydrolyze bonds involving the carboxyl...; Region:
Peptidase_C19D; cd02660"
/db_xref="CDD:73066"
misc_feature order(742..744,757..759,1639..1641,1690..1692)
/gene="USP22"
/gene_synonym="USP3L"
/note="active site"
/db_xref="CDD:73066"
exon 376..508
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 509..622
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 623..724
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 725..894
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 895..1042
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
variation 932..933
/gene="USP22"
/gene_synonym="USP3L"
/replace=""
/replace="a"
/db_xref="dbSNP:35693024"
exon 1043..1148
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 1149..1307
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
variation 1200..1201
/gene="USP22"
/gene_synonym="USP3L"
/replace=""
/replace="c"
/db_xref="dbSNP:36014709"
exon 1308..1434
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
variation 1413
/gene="USP22"
/gene_synonym="USP3L"
/replace="a"
/replace="c"
/db_xref="dbSNP:11541311"
exon 1435..1526
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 1527..1589
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 1590..1739
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
exon 1740..5220
/gene="USP22"
/gene_synonym="USP3L"
/inference="alignment:Splign:1.39.8"
variation 1981
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="g"
/db_xref="dbSNP:11541314"
variation 2441
/gene="USP22"
/gene_synonym="USP3L"
/replace="a"
/replace="g"
/db_xref="dbSNP:11541317"
variation 2847
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:1061971"
STS 2946..3080
/gene="USP22"
/gene_synonym="USP3L"
/standard_name="G43517"
/db_xref="UniSTS:94974"
STS 2946..3074
/gene="USP22"
/gene_synonym="USP3L"
/standard_name="G59516"
/db_xref="UniSTS:136679"
variation 3097
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:11541315"
variation 3242
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:11541318"
variation 3457
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:1044410"
variation 3675
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:1044414"
variation 3834
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:1127814"
variation 3895
/gene="USP22"
/gene_synonym="USP3L"
/replace="a"
/replace="g"
/db_xref="dbSNP:1127815"
variation 4074
/gene="USP22"
/gene_synonym="USP3L"
/replace=""
/replace="a"
/db_xref="dbSNP:35507774"
variation 4350
/gene="USP22"
/gene_synonym="USP3L"
/replace="a"
/replace="g"
/db_xref="dbSNP:1044420"
variation 4448
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="t"
/db_xref="dbSNP:11541313"
variation 4658
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="g"
/db_xref="dbSNP:3203817"
STS 4965..5157
/gene="USP22"
/gene_synonym="USP3L"
/standard_name="SHGC-133091"
/db_xref="UniSTS:171011"
variation 5046
/gene="USP22"
/gene_synonym="USP3L"
/replace="g"
/replace="t"
/db_xref="dbSNP:1045162"
variation 5058
/gene="USP22"
/gene_synonym="USP3L"
/replace="g"
/replace="t"
/db_xref="dbSNP:6618"
STS 5075..5164
/gene="USP22"
/gene_synonym="USP3L"
/standard_name="SHGC-64270"
/db_xref="UniSTS:53816"
variation 5167
/gene="USP22"
/gene_synonym="USP3L"
/replace="c"
/replace="g"
/db_xref="dbSNP:1045215"
ORIGIN
gcagccgcagctcgggggcggtgcctgccttgcagcctcccctcggcgatcgcgcagccccatctttgtccggcctccgcgctttgttctcggcgcccgggccttggccagcctggccagccgccgagcagcccccacgccgcgctggcgtcgtcctcgcctccctcgccgccgccccccgcgcgcggccgggccttgccccccatggtgtcccggccagagcccgagggcgaggccatggacgccgagctggcggtagcgccgccgggctgctcgcacctgggcagcttcaaggtggacaactggaagcagaacctgcgggccatctaccagtgcttcgtgtggagcggcacggctgaggcccgcaagcgcaaggccaagtcctgtatctgccatgtctgtggcgtccacctcaacaggctgcattcctgcctctactgtgtcttcttcggctgtttcacaaagaagcatattcacgagcatgcgaaggcgaagcggcacaacctggccattgatctgatgtacggaggcatctactgttttctgtgccaggactacatctatgacaaagacatggaaataatcgccaaggaggagcagcgaaaagcttggaaaatgcaaggcgttggagagaagttttcaacttgggaaccaaccaaacgggagcttgaactgctgaagcacaacccgaaaaggagaaagatcacctcgaactgcaccataggtctgcgtgggctgatcaaccttgggaacacatgcttcatgaactgcatcgtgcaggccctgacccacacgccacttctgcgggacttcttcctgtctgacaggcaccgctgtgagatgcagagccccagctcctgtctggtctgtgagatgtcctcactgtttcaggagttttactctggacaccggtcccctcacatcccgtataagttgctgcacctggtgtggacccacgcgaggcacctagcaggctacgagcagcaggacgcccacgagttcctcatcgcggccctggacgtgctccaccgacactgcaaaggtgatgacaatgggaagaaggccaacaaccccaaccactgcaactgcatcatagaccagatcttcacaggcgggttgcagtcagacgtcacctgccaagtctgccatggagtctccaccaccatcgaccccttctgggacatcagcttggatctccccggctcttccaccccattctggcccctgagcccagggagcgagggcaacgtggtaaacggggaaagccacgtgtcgggaaccaccacgctcacggactgcctgcgacgattcaccagaccagagcacttgggcagcagcgccaagatcaagtgcagcggttgccatagctaccaggagtccacaaagcagctcactatgaagaaactgcccatcgtagcctgttttcatctcaaacgatttgaacactcagccaagctgcggcggaagatcaccacgtatgtgtccttccccctggagctggacatgacccctttcatggcctccagcaaagagagcaggatgaatggacagtaccagcagcccacggacagtctcaacaatgacaacaagtattccctgtttgctgttgttaaccatcaagggaccttggagagtggccactacaccagctttatccggcagcacaaagaccagtggttcaagtgtgacgatgccatcatcaccaaggccagcatcaaggacgtcctggacagcgaagggtacttgctgttctatcacaaacagttcctggaatacgagtagccttatctgcagctggtcagaaaaacaaaggcaatgcattggcaagcctcacaaagtgatcctccctggcccccccctcccccaagtctcccgccgcctccccggcctggtgacaccacctcccatgcagatgtggcccctctgcacctgggacccatcgggtcgggatggaccacacggacggggaggctcctggagctgctttgaagatggatgagatgaggggtgtgctctgggtgggaggagcagcgtacacccgtcaccagaacatctcttgtgtcatgacatgggggtgcaacgggggcctcacagcacagagtgaccgctgcctggcgttccccagcactcggtgtggaaaggcccctacctgctgtaagattatgggtccatgaaagcagtaagctggacacagaggtgtagtgtgcgggacagagggccttgcagatgcctttctgttggtgttttagtgttaaaatacggagagtatggaactcttcacctccattttctcagcggctgtgaagcagcctcctagcttcggaagtacggacactacgtcgcgttttcaagcgtgtctgttctgcaggtaacagcatcaagctgcacgtggaagcatctcgcggttttctagaaacaggcattttcttatccctctcccgctcctttttccacaaaggtgaatttcataaatgtaatactagtaaagtgaatgaattactgagtttatacagaaatttaggtaacttctcctttagtctcaagagcgagtcttgctttttaatgggtgccgtttatgttgctgcccgccctgtgtgcctggctcctctgggtgccttggtgtctgctggtggctggcagtgggcgcagcggaggagagttgtgctgcagctcatacggtgtgtctgtcatctcagtctggagtaaatgcagtgtctgccggtgtctgatgggttctgtccctcgtattttctttgccttctatcccattgcctggctaccgctgcctggcagccaagggtgttggtcgcgaagctggagtggcctctggtggagcctgcatcttgtctcgtctgcctctgctttacatttggtgtactttcgggcgtggtggcagtaaaatgacaccgtgattgagcttgtcagcagagctgaaagagaaagtagaaggatgtgcattgtttcttgtaagatatcttgcatgtatctgtgtattcaaattcaaacagagatggtttgtccatttgtccactgagaaattagaaactagggacaagggggaggaaaagtactgaaatacagtttatgaagcaagtgtgtctcgggctgtgcttgtcccaggagccccagcagcatctgaactgaggcttcttcagtcctgcaggaacaggatcatctgtctcagcggtgggcagatgttttcatagacagccagggagtaaacactgttggctctgtgggctgtatggtctctgccataaatagtacagagatgtggctgtgtctagtacaacttttagacacagaaatctgaatgacatatattgttctgtgtcaagaaacttagattttttttttaactatttaaaaacgtgaaacctattcttagctcacaggccatggagaagctggtggggaccagacccagctccttagctggctgggctggggagggggtagtgacagtggcagctgctactcactgctcagtgtggaaaacacaggacttggcaatcacagcccgcagaaccatcatgtgtggcagaagcctgagggatgcggtttcttgcccacgtgctctgttcattttctgttgtttttctgcacttaaagaattcacatggaagcatgttttataaaatgaattaccagagaaacagagatgggccgagattttcagaaatggtcccatgtgaccaagttctgctgtttgggtgacagtgctttgaagatctcctttgaggatgtgcagtctttttttttttttttttgagatggagtttgttgcccaggctggagtgagtggcacagtctcggctcactgcaacctccacctcctgggttcaagcagttctcgtgccgcagcctcccaagtagctgggactacaggcatgcaccaccacgccaggctaatttttgtatttttagtagagatggggtttcaccatgtctcaaactcctgacctcaggcgatccacccacctcagcgtcccaaagtgctgggattataggcgtgagccaccgcacctggcctatgagtggtcttttaattaggaacaaatctaatggaaaggagagttgactgaagttggcccacaggattgtgagctgggcagtgccttcatgaaggcttgccaccttgggacgccccagtttactggggtgtcttgcggagtgcagaaggctttctggcagctgcctgggtttggccagaccctgcctcccctcccgccggccaacccctagtccccttcctgtctccacttgcattcaggggtggctgctgttctgagaacattagaactgggaagagagatggagtcacatggatttttggtgggcattattctaaactttcgtatccaagttagtcccccttattccactgtggcattgccgttctaagcagttacctgatgcctgctgctgaagagctgctcacaggaggcggcggcggccctggcactgccccttgcattaggtcttgtgtttgatgtgttcttgtgaatttactttgtcagaacaaaatatttacgcgttgggttcaggaatttcttttagctccccatctggctgtgaaattcaggaaacctcccgttgcctagtaatcaccccatgtaggtgtacattgtgacaaagtgcatctgaccactaaggggcccccttggtgaccccagcacattcacagcagtgttaaaatggcctgcattttggagatgctggctggcctttcagtgcctcccaggaagacacatggcctttccctcttcagatgcctgaagggagtgctttgaggcaggtgatgtgctgggagtgtgggcggcctccctctggccccggggccctctgtggaccttggctccctccgtggacctgggcttcgtggtgagcactgcagcctccctgggcattccctccagcgccagcaccactgcaacatatagacctgagtgctattgtattttggcttggtgtgtatgctcttcattgtgtaaaattgctgttcttttgacaatttaagtgattgttttgtttactgtaagtttgaaaataaaaatgaagaaaaaaattccaatgactgtgctgtggttggagactttatttaccaagatgtttactcttcctttccccttccattttgaggagctgtgtcactcctcctcccccccagtgctttgtagtctctcctatgtcataataaagctacattttctctgagaa
//
ANNOTATIONS from NCBI Entrez Gene (20130726):
GeneID:23326 -> Molecular function: GO:0003713 [transcription coactivator activity] evidence: IDA
GeneID:23326 -> Molecular function: GO:0004221 [ubiquitin thiolesterase activity] evidence: IEA
GeneID:23326 -> Molecular function: GO:0004843 [ubiquitin-specific protease activity] evidence: IDA
GeneID:23326 -> Molecular function: GO:0004843 [ubiquitin-specific protease activity] evidence: IMP
GeneID:23326 -> Molecular function: GO:0005515 [protein binding] evidence: IPI
GeneID:23326 -> Molecular function: GO:0008270 [zinc ion binding] evidence: IEA
GeneID:23326 -> Molecular function: GO:0010485 [H4 histone acetyltransferase activity] evidence: IDA
GeneID:23326 -> Molecular function: GO:0030374 [ligand-dependent nuclear receptor transcription coactivator activity] evidence: IMP
GeneID:23326 -> Biological process: GO:0006351 [transcription, DNA-dependent] evidence: IEA
GeneID:23326 -> Biological process: GO:0006511 [ubiquitin-dependent protein catabolic process] evidence: IEA
GeneID:23326 -> Biological process: GO:0007049 [cell cycle] evidence: IEA
GeneID:23326 -> Biological process: GO:0009790 [embryo development] evidence: NAS
GeneID:23326 -> Biological process: GO:0016574 [histone ubiquitination] evidence: IDA
GeneID:23326 -> Biological process: GO:0016578 [histone deubiquitination] evidence: IDA
GeneID:23326 -> Biological process: GO:0016579 [protein deubiquitination] evidence: IDA
GeneID:23326 -> Biological process: GO:0043967 [histone H4 acetylation] evidence: IDA
GeneID:23326 -> Biological process: GO:0045893 [positive regulation of transcription, DNA-dependent] evidence: IMP
GeneID:23326 -> Biological process: GO:0045931 [positive regulation of mitotic cell cycle] evidence: IMP
GeneID:23326 -> Cellular component: GO:0000124 [SAGA complex] evidence: IDA
GeneID:23326 -> Cellular component: GO:0070461 [SAGA-type complex] evidence: IDA
ANNOTATIONS from NCBI Entrez Gene (20130726):
NP_056091 -> EC 3.4.19.12
by
@meso_cacase at
DBCLS
This page is licensed under a Creative Commons Attribution 2.1 Japan License.